Close Menu

NEW YORK — Cancer Genetics said on Thursday that it had resolved all outstanding issues related to its failed merger with NovellusDx as it works with an advisor to evaluate other potential strategic transactions.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.